NOX1触发铁和铁性,有助于帕金森病的发生
Huiqing Wang1, Wenwei Mao2, Yuhan Zhang2
1School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, People's Republic of China.
Free radical biology & medicine
|June 14, 2024
概括
这项研究确定NOX1是帕金森病 (PD) 铁灭中的关键基因. NOX1的上调有助于神经退行,这表明NOX1是PD的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 的特征是多巴胺基神经元损失.
- 铁亡,一种溶性细胞死亡形式,越来越多地涉及到PD的病变发生.
- 与PD相关的铁灭症的致病基因和治疗策略需要进一步阐明.
研究的目的:
- 为了研究铁与帕金森病有关的基因在帕金森病中的作用.
- 为了确定特定的基因和途径参与PD相关的铁亡.
- 探索PD的潜在治疗点.
主要方法:
- 对PD患者的生物信息分析,以确定与铁死相关的基因.
- 构建体外和体外PD模型.
- 定量PCR,西部斑点,免疫组织化学,免疫光和铁化试验 (费罗色,BODIPY C11).
- 转录组学测序和免疫沉试验.
主要成果:
- 鉴定出NOX1是一种基因,与PD患者的铁亡有差异关联.
- 在PD模型中证实了NOX1上调.
- 观察到与铁亡相关的途径的激活,有助于神经退行.
结论:
- 在帕金森病中,NOX1上调对铁死介导的神经退行起着重要作用.
- 向NOX1可能为PD提供一种新的治疗策略.
- NOX1代表了帕金森病的潜在临床治疗剂.
更多相关视频
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
890
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
7.6K
相关概念视频
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
